Anti‐IgE (omalizumab) has been used for the treatment of moderate‐to‐severe asthma that is not controlled by inhaled steroids. Despite its success, it does not always provide patients with significant clinical benefits.

中文翻译：

---

接受奥马珠单抗治疗的哮喘患者中应答者和非应答者之间的全血转录变异

抗 IgE（奥马珠单抗）已用于治疗无法通过吸入类固醇控制的中度至重度哮喘。尽管取得了成功，但它并不总能为患者带来显着的临床益处。